InsidersTradesSigma
Total declarations
Companies
▲ Purchases (18 ops.)
▼ Sales (9 ops.)
Insider track record
OtherDisclosed buys
18
Disclosed sells
9
T+90 hit rate
0%
T+90 mean return
-31.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Redmile Group, LLC. Insider active across 17 companies, notably Fate Therapeutics INC. Cumulatively, 81 disclosures have been recorded. Split: 18 buys · 9 sells. Total volume traded: €43m. Activity tracked since 2 June 2021. The latest transaction was filed on 6 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Redmile Group, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations81 total
782,854 sharesCommon StockSEC:0001104659-26-092867:0
200,000 shares@ US$17.000.15% mcap33.3% of flowCommon StockSEC:0001104659-26-092867:1
Canonical exit: 4 Nov 2026 (T+90)
400,000 shares@ US$17.000.30% mcap66.7% of flowCommon StockSEC:0001104659-26-092867:2
Canonical exit: 4 Nov 2026 (T+90)
60 sharesCommon StockSEC:0001104659-26-086733:1
195,211 sharesCommon StockSEC:0001104659-26-086733:0
8,977,624 shares0Common StockSEC:0001104659-26-047072:0
8,977,624 shares0Common StockSEC:0001104659-26-047072:1
196,229 shares@ US$3.7523.5% of flowCommon StockSEC:0001104659-26-039359:0
188,407 shares@ US$3.7523.4% of flowCommon StockSEC:0001104659-26-039359:1
169,265 shares@ US$3.7993.0% of flowCommon StockSEC:0001104659-26-039359:2
162,517 shares@ US$3.7992.9% of flowCommon StockSEC:0001104659-26-039359:3
2,634,506 shares@ US$3.27941.1% of flowCommon StockSEC:0001104659-26-039359:4
2,529,491 shares@ US$3.27939.5% of flowCommon StockSEC:0001104659-26-039359:5
2,964,843 sharesCommon StockSEC:0001104659-25-079307:0
828 shares0Common StockSEC:0001104659-25-065256:0
828 shares0Common StockSEC:0001104659-25-031353:0
1,734 shares0Common StockSEC:0001104659-25-000432:0
1,084,936 shares@ US$1.6823.6% of flowCommon StockSEC:0001104659-24-131794:0
30,110 sharesCommon StockSEC:0001104659-24-129070:0
50,000 shares@ US$2.289.0% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-128575:0
Canonical exit: 11 Mar 2025 (T+90)
133,371 shares@ US$1.25100.0% of flowCommon Stock, par value $0.0001 per shareSEC:0001104659-24-126421:0
25,352 shares@ US$2.074.1% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-126422:0
16,421,788 shares@ US$2.3559.5% of flowCommon StockSEC:0001104659-24-106315:0
1,734 shares0Common StockSEC:0001104659-24-105559:0
400,000 shares@ US$2.8186.9% of flowCommon Shares, par value CHF 0.08 per shareSEC:0001104659-24-077865:0
Canonical exit: 29 Sept 2024 (T+90)
25 of 81 declarations
About Redmile Group, LLC
Redmile Group, LLC has 76 filings in total. In the sampled recent filings we hold, from 2016-01-11 to 2026-04-22, the reported buy amount is EUR 16224333 and the reported sell amount is EUR 52839723. The modal transaction nature is Attribution; the listed companies include IGM Biosciences, Inc., Augmedix, Inc., Fate Therapeutics INC, ADC Therapeutics SA, ARRAY BIOPHARMA INC, and Science 37 Holdings, Inc.
